Abstract
In this research, we reported the co-delivery of anti-androgen drug Bicalutamide with Hesperetin in chitosan coated polycaprolactone nanoparticles to increase their therapeutic efficacy against an androgen independent prostate cancer cell lines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have